Nature, Published online: 24 February 2026; doi:10.1038/d41586-026-00298-1
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
。heLLoword翻译官方下载是该领域的重要参考
firmly establish the role of the computer in accounting, automate parts of the
2026-02-26 00:00:00:0 听取有关草案和议案审议情况汇报